CONTROLE GENETIQUE DE LA MUTABILITE CHEZ LES SOURIS DE LABORATOIRE. I. ANALYSE GENETIQUE DE LA SENSIBILITE DES LIGNEES 101/H ET C57BL/6 A L'ACTION MUTAGENE DU THIOPHOSPHAMIDESURKOVA NI; MALASHENKO AM.1977; GENIKA; S.S.S.R.; DA. 1977; VOL. 13; NO 9; PP. 1572-1578; ABS. ANGL.; BIBL. 10 REF.Article

Successful engraftment and stable full donor chimerism after myeloablation with thiotepa, fludarabine, and melphalan and CD34-selected peripheral allogeneic stem cell transplantation in hemophagocytic lymphohistiocytosisCESARO, Simone; GAZZOLA, Maria Vittoria; MESSINA, Chiara et al.American journal of hematology. 2003, Vol 72, Num 2, pp 143-146, issn 0361-8609, 4 p.Article

Relations between polymorphisms in drug-metabolising enzymes and toxicity of chemotherapy with cyclophosphamide, thiotepa and carboplatinEKHART, Corine; RODENHUIS, Sjoerd; SMITS, Paul H. M et al.Pharmacogenetics and genomics (Print). 2008, Vol 18, Num 11, pp 1009-1015, issn 1744-6872, 7 p.Article

EFFETS DE DIVERS ANTIMITOTIQUES SUR LES GLIOMES HUMAINES, EN CULTURE: MISE EN EVIDENCE DE DEUX TYPES D'ATTEINTES MORPHOLOGIQUES SIMULTANEES, SPECIFIQUES ET NON SPECIFIQUESHUMEAU C; VIC P; ARNAL F et al.1981; C.R. SOC. BIOL. FIL.; ISSN 0037-9026; FRA; DA. 1981; VOL. 175; NO 2; PP. 213-220; ABS. ENG; BIBL. 12 REF.Article

Cutaneous effects of thiotepa in pediatric patients receiving high-dose chemotherapy with autologous stem cell transplantationROSMAN, Ilana S; LLOYD, Brendan M; HAYASHI, Robert J et al.Journal of the American Academy of Dermatology. 2008, Vol 58, Num 4, pp 575-578, issn 0190-9622, 4 p.Article

High-dose Chemotherapy with Autologous Stem Cell Rescue in Stage IIIB Inflammatory Breast CancerYALAMANCHILI, Kiran; LALMUANPUII, Judy; CHUN, Hoo G et al.Anticancer research. 2008, Vol 28, Num 5B, pp 3139-3142, issn 0250-7005, 4 p.Article

Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancerBIRON, P; DURAND, M; TANGUY, M. L et al.Bone marrow transplantation (Basingstoke). 2008, Vol 41, Num 6, pp 555-562, issn 0268-3369, 8 p.Article

Autologous hematopoietic stem cell transplant with melphalan and thiotepa is safe and feasible in pediatric patients with low normalized glomerular filtration rateTERMUHLEN, Amanda M; GROVAS, Alfred; KLOPFENSTEIN, Kathryn et al.Pediatric transplantation. 2006, Vol 10, Num 7, pp 830-834, issn 1397-3142, 5 p.Article

Topotecan, thiotepa, and carboplatin for neuroblastoma : failure to prevent relapse in the central nervous systemKUSHNER, B. H; KRAMER, K; MODAK, S et al.Bone marrow transplantation (Basingstoke). 2006, Vol 37, Num 3, pp 271-276, issn 0268-3369, 6 p.Article

Accuracy, feasibility, and clinical impact of prospective Bayesian pharmacokinetically guided dosing of cyclophosphamide, thiotepa, and carboplatin in high-dose chemotherapyDE JONGE, Milly E; HUITEMA, Alwin D. R; TUKKER, Annemarie C et al.Clinical cancer research. 2005, Vol 11, Num 1, pp 273-283, issn 1078-0432, 11 p.Article

Inhibition of human CYP2B6 by N, N', N-triethylenethiophosphoramide is irreversible and mechanism-basedRICHTER, Tanja; SCHWAB, Matthias; EICHELBAUM, Michel et al.Biochemical pharmacology. 2005, Vol 69, Num 3, pp 517-524, issn 0006-2952, 8 p.Article

High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients : high toxicity and lack of efficacyVALTEAU-COUANET, D; FILLIPINI, B; BENHAMOU, E et al.Bone marrow transplantation (Basingstoke). 2005, Vol 36, Num 11, pp 939-945, issn 0268-3369, 7 p.Article

Double high-dose chemotherapy with adriamycin, paclitaxel, cyclophosphamide, and thiotepa followed by autologous peripheral blood stem cell transplantation in women with metastatic breast cancerSAYER, Herbert G; SCHILLING, Kristina; VOGT, Tobias et al.Journal of cancer research and clinical oncology. 2003, Vol 129, Num 6, pp 361-366, issn 0171-5216, 6 p.Article

Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatinHUITEMA, A. D. R; SPAANDER, M; MATHOT, R. A. A et al.Annals of oncology. 2002, Vol 13, Num 3, pp 374-384, issn 0923-7534Article

Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: Results of the Chicago Pilot II StudyKLETZEL, Morris; KATZENSTEIN, Howard M; SHORE, Richard M et al.Journal of clinical oncology. 2002, Vol 20, Num 9, pp 2284-2292, issn 0732-183XArticle

Impact of complete remission with intensive therapy in patients with responsive multiple myelomaALEXANIAN, R; WEBER, D; GIRALT, S et al.Bone marrow transplantation (Basingstoke). 2001, Vol 27, Num 10, pp 1037-1043, issn 0268-3369Article

Neoadjuvant high dose chemotherapy plus peripheral blood progenitor cells in inflammatory breast cancer : a multicenter phase II pilot studyDAZZI, Claudio; CARIELLO, Anna; MARANGOLO, Maurizio et al.Haematologica (Roma). 2001, Vol 86, Num 5, pp 523-529, issn 0390-6078Article

Ototoxicity after high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin followed by stem cell transplantation in patients with breast cancerJILLELLA, A. P; BRITT, G. W; LITAKER, M. S et al.Medical oncology (Northwood). 2000, Vol 17, Num 4, pp 287-292, issn 1357-0560Article

Malignant cardiac tamponade in women with breast cancer treated by pericardiocentesis and intrapericardial administration of triethylenethiophosphoramide (Thiotepa)BISHINIOTIS, T. S; ANTONIADOU, S; KATSEAS, G et al.The American journal of cardiology. 2000, Vol 86, Num 3, pp 362-364, issn 0002-9149Article

High-dose chemotherapy with peripheral blood stem cell support for stage IIIB inflammatory carcinoma of the breastSCHWARTZBERG, L. S; WEAVER, C. H; LEWKOW, L et al.Bone marrow transplantation (Basingstoke). 1999, Vol 24, Num 9, pp 981-987, issn 0268-3369Article

Hprt mutant frequency and molecular analysis of Hprt mutations in Fischer 344 rats treated with thiotepaTAO CHEN; AIDOO, A; MITTELSTAEDT, R. A et al.Carcinogenesis (New York. Print). 1999, Vol 20, Num 2, pp 269-277, issn 0143-3334Article

Inappropriate antidiuretic hormone secretion after high-dose thiotepaSICA, S; CICCONI, S; SORA, F et al.Bone marrow transplantation (Basingstoke). 1999, Vol 24, Num 5, pp 571-572, issn 0268-3369Article

Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumorsHARA, J; OSUGI, Y; OKADA, S et al.Bone marrow transplantation (Basingstoke). 1998, Vol 22, Num 1, pp 7-12, issn 0268-3369Article

Thiotepa and cyclophosphamide with stem cell rescue for consolidation therapy for children with high-risk neuroblastoma : A phase I/II study of the pediatric blood and marrow transplant consortiumKLETZEL, M; ABELLA, E. M; SANDLER, E. S et al.Journal of pediatric hematology/oncology. 1998, Vol 20, Num 1, pp 49-54, issn 1077-4114Article

Durable remission of locally advanced breast cancer with multimodality managementMILLER, A; KHOSLA, P; MENDENHALL, N et al.Medical oncology (Northwood). 1998, Vol 15, Num 2, pp 89-95, issn 1357-0560Article